CME Group (CME) Stock
Key stats
- Market cap
- $113.06B
- Price / Earnings ratio
- 25.1x
- EPS (TTM)
- $12.29
- Volume
- Loading
- 52-week high
- $329.16
- 52-week low
- $218.31
- Dividend yield
- 3.58%
- Dividend amount (latest)
- $1.30
- EPS vs analyst estimate
- +1.9%Q3 FY25 · $2.68 vs $2.63
Source: third-party data provider, as of November 13, 2026
EPS estimate: analyst consensus
Compare with CME
Recent news

The CFTC Just Cleared Stock Perpetual Futures for U.S. Exchanges. Does That Hurt Hyperliquid?
The CFTC Just Cleared Stock Perpetual Futures for U.S. Exchanges. Does That Hurt Hyperliquid?
CME

CME vs. Interactive Brokers Group: Which Financial Stock Is a Better Buy for 2027?
CME vs. Interactive Brokers Group: Which Financial Stock Is a Better Buy for 2027?
CME

CME Group's Market Data Revenue Hit a Record $243 Million Last Quarter. Can It Carry the Stock When Trading Slows?
CME Group's Market Data Revenue Hit a Record $243 Million Last Quarter. Can It Carry the Stock When Trading Slows?
CME

Rate Hikes Could Be Coming: History Likes These 4 Stocks
Rate Hikes Could Be Coming: History Likes These 4 Stocks
CME
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 70.56
- MACD 12/26/9
- 7.80
- EMA 9 of MACD
- 7.48
- MACD histogram
- 0.32
- SMA 50
- $284.53
- Price above SMA 50
- EMA 50
- $288.57
- Price above EMA 50
- SMA 200
- $281.28
- Price above SMA 200
- EMA 200
- $281.82
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 8 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $2.86 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

The CFTC Just Cleared Stock Perpetual Futures for U.S. Exchanges. Does That Hurt Hyperliquid?
The CFTC Just Cleared Stock Perpetual Futures for U.S. Exchanges. Does That Hurt Hyperliquid?
CME

CME vs. Interactive Brokers Group: Which Financial Stock Is a Better Buy for 2027?
CME vs. Interactive Brokers Group: Which Financial Stock Is a Better Buy for 2027?
CME

CME Group's Market Data Revenue Hit a Record $243 Million Last Quarter. Can It Carry the Stock When Trading Slows?
CME Group's Market Data Revenue Hit a Record $243 Million Last Quarter. Can It Carry the Stock When Trading Slows?
CME

Rate Hikes Could Be Coming: History Likes These 4 Stocks
Rate Hikes Could Be Coming: History Likes These 4 Stocks
CME

Crypto ETFs Already Go Far Beyond Bitcoin. The SEC Wants to Know If Its Rules Have Kept Up
Crypto ETFs Already Go Far Beyond Bitcoin. The SEC Wants to Know If Its Rules Have Kept Up
CME

CME vs. Morningstar: Scale vs. Consistent Trajectories in Revenue
CME vs. Morningstar: Scale vs. Consistent Trajectories in Revenue
CME

CME Group CEO Terry Duffy: From the Trading Floor to the Future of Markets
CME Group CEO Terry Duffy: From the Trading Floor to the Future of Markets
CME

CME (CME) Upgraded to Buy: Here's Why
CME (CME) Upgraded to Buy: Here's Why
CME

CME vs. Mastercard: Which Financial Stock Is a Better Buy in 2026?
CME vs. Mastercard: Which Financial Stock Is a Better Buy in 2026?
CME

CME Group vs. Coinbase Global: Steady Growth Meets Crypto's Boom-and-Bust Cycle
CME Group vs. Coinbase Global: Steady Growth Meets Crypto's Boom-and-Bust Cycle
CME
News tone: automated (AI) classification of the article's content, not a price prediction.
About CME Group
As the world's leading and most diverse derivatives marketplace, CME Group is where the world comes to manage risk. Comprised of four exchanges - CME, CBOT, NYMEX and COMEX - we offer the widest range of global benchmark products across all major asset classes, helping businesses everywhere mitigate the myriad of risks they face in today's uncertain global economy.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Terrence A. Duffy | Chairman & CEO | 1958 |
| Ms. Lynne C. Fitzpatrick | Senior MD, President & CFO | 1978 |
| Ms. Suzanne Sprague | Senior MD, Group COO & Global Head of Clearing | — |
| Mr. Sunil Cutinho | Chief Information Officer | 1972 |
| Mr. Derek L. Sammann | Senior MD & Global Head of Commodities Markets | 1968 |
| Ms. Julie M. Winkler | Senior MD & Chief Commercial Officer | 1975 |
| Mr. Jack Tobin | MD & Chief Accounting Officer | 1964 |
| Adam Minick | Investor Contact | — |
| Mr. John Clifford Marchese | General Counsel | 1968 |
| Ms. Anita Liskey | Senior Managing Director of Corporate Marketing & Communications | 1965 |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 70.56
- MACD 12/26/9
- 7.80
- EMA 9 of MACD
- 7.48
- MACD histogram
- 0.32
- SMA 50
- $284.53
- Price above SMA 50
- EMA 50
- $288.57
- Price above EMA 50
- SMA 200
- $281.28
- Price above SMA 200
- EMA 200
- $281.82
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
8 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $270.00
- Average
- $323.75
- High
- $367.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -2.7 | +3.8 | ||||||||||
| 2022 | +1.8 | +1.9 | +1.9 | -8.5 | -8.3 | +2.7 | -2.3 | -0.1 | -11.2 | -2.7 | +1.7 | -5.5 |
| 2023 | +4.6 | +5.6 | +4.0 | -2.4 | -4.2 | +2.9 | +6.9 | +1.4 | -1.3 | +6.7 | +3.5 | -4.1 |
| 2024 | -1.6 | +7.1 | -1.8 | -1.1 | -2.4 | -2.6 | -0.9 | +9.9 | +3.8 | +0.0 | +6.4 | -1.4 |
| 2025 | +1.6 | +5.5 | +3.3 | +5.7 | +4.3 | -5.2 | +1.0 | -5.1 | +1.8 | -0.1 | +6.5 | -2.1 |
| 2026 | +7.2 | +9.9 | -9.5 | -3.1 | -5.5 | -14.3 | +15.9 | +7.3 | -8.5 | +14.3 | +0.9 |



